Galenica Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Dive Deeper Into the Activities Behind the Analysis
This Galenica Value Chain Analysis gives a clear, structured view of how Galenica creates value across its support and primary activities. The page already shows a real preview of the actual analysis, so you can review the content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Galenica's firm infrastructure is built around central management, which coordinates the Swiss pharmacy network, wholesale logistics, and own-brand development across Amavita, Coop Vitality, and Sun Store. In 2025, Galenica reported about CHF 4.0 billion in net sales, showing how tightly this structure links retail and B2B execution. The same layer supports compliance, capital allocation, and network planning, so pharmacy openings, supply flows, and brand decisions stay aligned across the group.
Human Resource Management
Human resource management is central at Galenica because pharmacists, pharmacy technicians, logistics staff, and retail managers keep over 500 pharmacies and healthcare sites running. Hiring, training, and shift planning support safe prescription handling, fast service, and reliable warehouse flow. In 2025, this matters even more as staffing gaps can hit store hours, stock availability, and customer trust.
Technology Development
Galenica's technology development links pharmacies, wholesale distribution, inventory control, and customer digital channels, so stock data and orders move faster across the 3 banners and B2B clients.
This setup improves stock visibility and order flow, which helps cut manual handoffs and supports tighter coordination across the network.
For Galenica, tech is a core support activity because it keeps supply, service, and customer access aligned.
Procurement
Galenica's procurement covers medicines, OTC products, healthcare items, and inputs for its own health and beauty range from manufacturers and suppliers. In a regulated market, tight sourcing controls help keep shelves stocked, protect gross margin, and reduce supply risk. Strong supplier terms also support faster replenishment and better cost control across Galenica's pharmacy and wholesale network.
Galenica's support engine powers a CHF 4.0 billion pharmacy network
Galenica's support activities keep the 2025 CHF 4.0 billion network moving: group infrastructure steers capital, compliance, and store rollout; HR keeps over 500 pharmacies staffed; tech links inventory and orders; procurement secures medicines and OTC stock.
| Support activity | 2025 data |
|---|---|
| Network scale | Over 500 sites |
| Net sales | CHF 4.0 billion |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
In fiscal 2025, Galenica handled medicines and healthcare products through wholesale supply chains and distribution centers that support a CHF 4.0 billion sales base. Careful intake, quality control, and inventory sorting matter because pharmacies, doctors, and hospitals rely on fast, compliant delivery. Any stock error can hit availability, so inbound logistics is a core service edge.
Operations
In 2025, Galenica turned sourced medicines and health goods into a wide retail and service network through Amavita, Coop Vitality, and Sun Store, plus wholesale fulfillment and own-brand development. That setup keeps shelves stocked and supports fast access to care across Switzerland. Galenica also used its own brands to lift margin and control the customer offer.
Outbound Logistics
Galenica's outbound logistics moves medicines and healthcare products from its wholesale network to pharmacies, medical practices, and hospitals. Fast, accurate replenishment helps cut stockouts and keeps high-volume retail and professional channels supplied. In 2025, this step mattered most where demand is daily and service levels need to stay high, so delivery speed and inventory control directly shape customer availability.
Marketing and Sales
Galenica's marketing and sales rely on local pharmacy advice, national banners, and wholesale ties, so it can reach customers at the counter and through B2B channels. In 2025, this setup helped drive repeat visits and support sales of own-brand health and beauty products alongside prescription and OTC items. It also matters because pharmacy-led advice can lift basket size and keep traffic flowing across the network.
Service
Galenica adds value through pharmacy advice, medication support, and post-purchase care that helps customers use prescription and everyday medicines correctly. This service layer matters most in Switzerland, where trusted guidance can drive repeat visits and stronger loyalty. In 2025, service quality was still a key reason people chose Galenica for both health advice and routine pharmacy needs.
Galenica's CHF 4.0B medicine flow powers retail and pharmacy growth
In fiscal 2025, Galenica's primary activities stayed centered on fast medicine flow across a CHF 4.0 billion sales base. Inbound handling, sorting, and quality checks protected availability for pharmacies, doctors, and hospitals. Retail and wholesale operations then moved products through Amavita, Coop Vitality, and Sun Store, while pharmacy advice supported repeat traffic and basket size.
| 2025 data point | Value |
|---|---|
| Sales base | CHF 4.0 billion |
| Main retail banners | Amavita, Coop Vitality, Sun Store |
Full Version Awaits
Galenica Reference Sources
This preview shows the actual Galenica Value Chain Analysis document you'll receive after purchase – nothing is changed or summarized. The full report includes the same professional structure and detailed content visible here. Once you complete checkout, the complete version is unlocked for immediate use.
Frequently Asked Questions
Galenica's integrated retail-and-wholesale model drives the value chain most. It links 3 pharmacy banners, 1 wholesale platform, and own-brand products across 3 customer groups: patients, doctors, and hospitals. That structure improves purchasing leverage, shelf availability, and local reach while keeping customer traffic and replenishment in one network.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.